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infarction, stroke, and death; thus, they consti­
tute the highest clinical priority for secondary 
prevention.3 The main foundations of secondary 
prevention of cardiovascular diseases include op­
timal pharmacotherapy and nonpharmacological 
modification of the risk factors, such as lifestyle 
change, increase in physical activity, optimal diet, 
and quitting unhealthy habits like smoking.4 Nev­
ertheless, establishment and optimal control of 
the risk factors in this cohort is still challenging.5
IntroductIon Cardiovascular diseases have 
been the leading cause of morbidity, disability, and 
mortality worldwide, despite the observed devel­
opment of new treatment methods as well as im­
provement in outcomes.1,2 Secondary prevention 
aims to prevent the recurrence of cardiovascular 
events in patients already diagnosed with cardio­
vascular diseases. Individuals with established 
cardiovascular disease are at a high risk for the oc­

















Background The goal of secondary prevention is to hinder the recurrence of cardiovascular events in 
patients already diagnosed with cardiovascular diseases.
aims We aimed to assess the level of adherence to guidelines for secondary prevention of cardiovascular 
disease in everyday clinical practice.
methods This was a single ‑center retrospective analysis of 460 consecutive rehospitalized patients 
previously diagnosed with coronary artery disease. The presence of main risk factors for cardiovascular 
disease was analyzed in this cohort.
results Overall, 80.7% of patients did not comply with the body mass index recommendations. Among 
nondiabetic patients, 43.5% exceeded the recommended blood glucose level and 55.5% of diabetic 
patients exceeded the recommended level of glycated hemoglobin. Total cholesterol level was higher 
than recommended in 13.5% of patients, the level of low ‑density lipoprotein (LDL) cholesterol was exceeded 
in 78.7% individuals, and the level of triglycerides was over the limit in 30.2% of patients. Systolic and / or 
diastolic blood pressure higher than or equal to 140/90 mm Hg was recorded in 41.3% of patients. Low 
level of physical activity was declared by 56.7% of the studied patients and 14.6% of them admitted to 
being current tobacco smokers. No patient fulfilled all of the main prevention goals (body weight, no 
smoking, LDL cholesterol level, glucose level, systolic and / or diastolic blood pressure) and in 10.2% of 
cases none of the above ‑mentioned criteria were achieved. Significant difference in the implementation 
level of the guidelines was found between the sexes, with men showing lower adherence than women.
conclusions The level of adherence to the guidelines for secondary prevention of coronary artery 
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percutaneous) or presence of any implantable car­
diac devices was noted. The presence of other co­
morbidities, especially chronic heart failure with 
reported symptoms assessed with the New York 
Heart Association Functional Classification, isch­
emic heart disease with symptoms evaluated with 
the Canadian Cardiovascular Society Angina Grad­
ing Scale, atrial fibrillation, diabetes mellitus, pul­
monary disorders, peptic ulcer disease, thyroid dis­
orders, previous cerebrovascular accidents (tran­
sient ischemic attack and / or stroke), and chron­
ic kidney disease was recorded based on patients’ 
medical history. Family history of early cardiovas­
cular disease (in men younger than 55 and wom­
en younger than 65 years) was also investigated.
The height and weight of patients were mea­
sured by medical staff on admission. The body 
mass index (BMI) was calculated as the body mass 
in kilograms divided by the square of the height in 
meters and expressed in units of kg/m2. Patients 
were classified as underweight (BMI ≤18.4 kg/m2), 
normal weight (BMI 18.5–24.9 kg/m2), over­
weight (BMI 25–29.9 kg/m2), and obese (BMI 
≥30 kg/m2), with the latter group further divid­
ed into class I (BMI 30–34.9 kg/m2), class II (BMI 
35–39.9 kg/m2), and class III (BMI ≥40 kg/m2), 
according to the guidelines of the World Health 
Organization and National Institutes of Health.11 
Additionally, waist circumference was measured. 
Abdominal overweight was defined as waist cir­
cumference of 95 to 102 cm in men and 81 to 
88 cm in women. Abdominal obesity was con­
sidered present if waist circumference was great­
er than 102 cm in men and greater than 88 cm 
in women.12
Fasting blood samples were collected on 
patient admission as well. The levels of low­
­density lipoprotein (LDL) cholesterol (target 
value, <1.4 mmol/l),13 total cholesterol (reference 
range, 3.2–5.2 mmol/l), high­density lipopro­
tein (HDL) cholesterol (target value, >1 mmol/l 
in men and >1.2 mmol/l in women), triglycerides 
(target value, ≤1.7 mmol/l),14 fasting glucose (in 
patients without diabetes mellitus; reference 
range, 3.9–5.5 mmol/l), and glycated hemoglobin 
(HbA1c) (in diabetic patients; target value, ≤7%)
15 
were measured. Blood pressure measurements 
were taken on the second day of hospitalization 
by medical staff. Elevated blood pressure was 
defined as systolic blood pressure greater than 
or equal to 140 mm Hg and / or diastolic blood 
pressure greater than or equal to 90 mm Hg.16 
Left ventricular ejection fraction was assessed 
using transthoracic echocardiography.
Dietary habits were assessed using a specially­
­designed, study ­dedicated questionnaire. It was 
focused on the consumption of saturated fatty ac­
ids, fiber, fruit, vegetables, fish, salt, and alcohol 
(Supplementary material). The level of physical ac­
tivity was evaluated by the short form of the In­
ternational Physical Activity Questionnaire,17,18 
which delineates 3 levels of physical activity: low, 
Adequate control of hypertension, dyslipid­
emia, diabetes, and heart failure as well as sig­
nificant lifestyle modifications allow to reduce 
the risk of recurrent cardio­ and cerebrovascu­
lar ischemic events. Nevertheless, many stud­
ies have shown that a large majority of patients 
with coronary diseases did not achieve the guide­
line standards for secondary prevention.6‑8 Indi­
vidual patient’s compliance played the most im­
portant role in the implementation of preven­
tive measures. However, large discrepancies in 
the realization of secondary prevention prac­
tices might be observed within different health 
systems and even between individual clinicians, 
which could lead to negative consequences for 
the patients.9,10 Identification of the fields of de­
viation from the official clinical practice guide­
lines might provide valuable conclusions on how 
to improve the quality of secondary prevention 
of cardiovascular events. Therefore, we aimed to 
assess the level of adherence to the guidelines for 
secondary prevention of cardiovascular disease 
in everyday clinical practice and compare some 
cardiovascular risk factors between the sexes.
Methods study population The present 
study was a single ­center retrospective analy­
sis of 460 consecutive patients (women, 26.1%) 
with previously diagnosed coronary artery dis­
ease who were rehospitalized due to subsequent 
cardiovascular event from June 2016 to Decem­
ber 2018 at the 2nd Department of Cardiology 
and Cardiovascular Interventions, University 
Hospital in Kraków, Poland—a tertiary refer­
ral medical center. All the patients had a history 
of previous percutaneous coronary intervention 
and / or coronary artery bypass grafting or cor­
onary artery disease treated pharmacological­
ly. The median time from last to current hospi­
talization was 10 months (range, 1–364 months) 
and median time from the diagnosis of coronary 
artery disease to current hospitalization was 58 
months (range, 1–461 months). This information 
was not available for 59 patients.
data collection and interpretation Demo­
graphics, baseline characteristics, and medi­
cal history data were collected from all patients. 
History of any cardiac interventions (surgical or 
whAt’s new?
Identification of the fields of deviation from the official clinical practice 
guidelines for secondary prevention of cardiovascular disease may provide 
valuable conclusions on how to improve the quality of secondary prevention 
of cardiovascular events. Our study demonstrated that the level of adherence 
to the guidelines in everyday clinical practice was extremely low. No patient 
fulfilled all of the prevention goals. Therefore, more attention should be paid 
to proper implementation of the guidelines and patients’ education to prevent 
progression of cardiovascular disease.
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Research) guidelines and analyzed according 
to the established statistical protocols. Contin­
uous variables were presented as mean (SD) or 
median with interquartile range (IQR) and cat­
egorical variables as numbers and percentages. 
The Shapiro–Wilk test was used to determine if 
the quantitative data were normally distribut­
ed. The t test, Mann–Whitney test, and χ2 test 
were used for statistical comparisons. A P val­
ue of less than 0.05 was considered significant. 
The STATISTICA software, version 13.1 (StatSoft 
Inc., Tulsa, Oklahoma, United States) was used 
to perform statistical analyses.
results baseline characteristics of the 
study population A total of 460 patients 
(women, 26.1%) at a mean (SD) age of 66.4 (9.9) 
years were enrolled in this study. Among them, 
62.4% had at least 1 myocardial infarction and 
26.1% had a history of 2 or more myocardial in­
farctions. Previous percutaneous coronary in­
tervention and coronary artery bypass grafting 
were performed in 81.1% and 10.7% of patients, 
respectively. Baseline characteristics and co­
morbidities of the patients are shown in TAblE 1.
body composition The median (IQR) recorded 
BMI was 28 (25.8–31.3) kg/m2; precisely, 0.4% of 
patients were underweight, 19.3% were within 
normal range of weight, 46.3% were overweight, 
and 33.9% were obese (class I, 25%; class II, 7.6%; 
class III, 1.3%). This indicated that 80.7% of all 
patients (82.9% of men and 74.2% of women; 
P = 0.04) did not comply with the BMI recom­
mendations for secondary prevention of coro­
nary artery disease (TAblE 2).
Based on waist circumference measurements, 
abdominal overweight was found in 26.7% of 
patients (30.3% of men and 16.7% of women; 
P = 0.004) and abdominal obesity in 38.5% 
(32.6% of men and 55% of women; P <0.001).
blood glucose levels In the study popula­
tion, 39.6% of patients were diabetic; 51.1% of 
them were treated only with oral diabetes med­
ications, 20.3% with a combination of oral anti­
diabetic agents and insulin therapy, 25.3% only 
with insulin injections, and 3.3% only with diet. 
The median (IQR) fasting glucose level in nondi­
abetic patients was 5.4 (5–5.8) mmol/l. Among 
the nondiabetic patients, 43.5% (46.7% of men 
and 33.3% of women; P = 0.056) had a fasting 
blood glucose level higher than 5.5 mmol/l and 
in 2.9% of cases (only men) this level was greater 
than or equal to 7 mmol/l. In diabetic patients, 
the HbA1c level was examined and the median 
(IQR) value was 7.2% (6.2%–8.1%), with 55.5% 
of diabetic patients (50.8% of men and 66.7% of 
women; P = 0.049) having the HbA1c level exceed­
ing 7%. Differences in the levels of blood glucose 
according to sex are shown in TAblE 2.
moderate, and high. Data regarding tobacco con­
sumption (a history of smoking, daily tobacco in­
take, and current tobacco use status) were also 
collected. Finally, the type of pharmacotherapy 
used by the patient on the day of admission to 
the hospital was noted.
The study protocol conformed to the ethical 
guidelines of the 1975 Declaration of Helsinki Oral 
informed consent was provided by all participants.
statistical analysis The data were present­
ed in agreement with the EQUATOR (Enhanc­
ing the Quality and Transparency Of health 
Table 1 Baseline clinical and demographic characteristics of patients (n = 460)
Variable Value
Age, y, mean (SD) 66.4 (9.9)
Male sex 340 (73.9)
Previous myocardial infarction 287 (62.4)
Previous percutaneous coronary intervention 373 (81.1)
Previous coronary artery bypass grafting 49 (10.7)










Left ventricular ejection fraction, %, median (IQR) 55 (43–60)
Hypertension 394 (85.6)
Diabetes mellitus 182 (27.8)
Hypercholesterolemia 376 (39.6)
Atrial fibrillation 91 (19.8)
Chronic obstructive pulmonary disease 68 (14.8)
Peptic ulcer disease 42 (9.1)
Thyroid disorders 67 (14.6)
Previous transient ischemic attack 5 (1.1)
Previous stroke 35 (7.6)
Family history of early cardiovascular disease 118 (25.7)
Presence of implantable pacemaker 25 (5.4)
Presence of cardiac resynchronization therapy device 7 (1.5)
Presence of implantable cardioverter defibrillator 11 (2.4)
Data are presented as number (percentage) unless otherwise indicated.
Abbreviations: CCS, Canadian Cardiovascular Society grading of angina pectoris; IQR, interquartile 
range; NYHA, New York Heart Association Functional Classification
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in 40% of patients (37.6% of men and 46.7% of 
women; P = 0.08) and diastolic blood pressure 
greater than or equal to 90 mm Hg was noted 
in 11.7% (12.4% of men and 10% of women; P = 
0.48). Systolic and / or diastolic blood pressure 
greater than or equal to 140/90 mm Hg was re­
corded in 41.3% of patients (39.1% of men and 
47.5% of women; P = 0.11) (TAblE 2).
dietary habits, physical activity, and tobac-
co use Low level of physical activity was noted 
in 56.7% of the studied patients (61.5% of men 
and 43.3% of women), moderate in 36.7% (31.2% 
of men and 52.5% of women), and high in 6.5% 
(7.4% of men and 4.2% of women). A difference 
in the level of physical activity was found be­
tween the sexes (P <0.001).
Dietary habits were assessed using study­
­dedicated questionnaires. Among all studied 
patients, 76.5% (75.3% of men and 80% of wom­
en) had changed their diet after the diagnosis 
blood lipid levels The median (IQR) level of total 
cholesterol was 3.8 (3.1–4.6) mmol/l and it exceeded 
the desirable level  in 13.5% of patients (9.7% of men 
and 24.2% of women; P <0.001). The median (IQR) 
level of LDL cholesterol was 1.9 (1.4–2.6) mmol/l, 
and it was higher than the level recommended by 
the guidelines in 78.7% of patients (77.4% of men 
and 82.5% of women; P = 0.24). The level of HDL 
cholesterol (median [IQR], 1.1 [0.9–1.3] mmol/l) 
was below the recommended level in 43.9% of pa­
tients (41.2% of men and 51.7% of women; P = 0.047), 
and the level of triglycerides (median [IQR], 1.3 
[1–1.8] mmol/l) was over the reference range in 
30.2% of patients (31.2% of men and 27.5% of wom­
en; P = 0.45) (TAblE 2).
blood pressure The median (IQR) value of sys­
tolic blood pressure was 135 (120–147) mm Hg, 
whi le for d iastol ic pressure it was 
75 (69–84) mm Hg. Systolic blood pressure 
greater than or equal to 140 mm Hg was observed 
Table 2 Results of the obtained measurements and the rate of patients not adhering to the guidelines for secondary prevention 
of cardiovascular disease
Variable All patients (n = 460) Men (n = 340) Women (n = 120) P value
Age, y, mean (SD) 66.4 (9.9) 65.7 (10) 68.2 (9.4) 0.02
Body mass index, kg/m2, median (IQR) 28 (25.8–31.3) 28 (25.9–31.1) 28 (24.9–31.7) 0.99
Obese or overweight patientsa, % 80.2 82.4 74.2 0.053
Waist circumference, cm, mean (SD) 96.3 (12.1) 98.5 (11.1) 89.7 (12.8) <0.001
Abdominal overweight or obesityb, % 65.2 62.9 71.7 0.08
Fasting blood glucose level in nondiabetic patients, mmol/l, 
median (IQR)
5.4 (5–5.8) 5.4 (5–5.9) 5.3 (5–5.6) 0.08
Fasting blood glucose level exceeding the recommendations 
(>5.5 mmol/l), %
43.5 46.7 33.3 0.056
HbA1c in diabetics, %, median (IQR) 7.2 (6.2–8.1) 7.1 (6.2–8) 7.4 (6.3–8.5) 0.16
HbA1c in diabetics exceeding the recommendations (>7%), % 55.5 50.8 66.7 0.049
Total cholesterol, mmol/l, median (IQR) 3.8 (3.1–4.6) 3.7 (3.1–4.4) 4 (3.5–5.2) 0.001
Total cholesterol >5.2 mmol/l, % 13.5 9.7 24.2 <0.001
LDL cholesterol, mmol/l, median (IQR) 1.9 (1.4–2.6) 1.8 (1.4–2.5) 2 (1.6–3.1) 0.02
LDL cholesterol ≥1.4 mmol/l, % 78.7 77.4 82.5 0.24
HDL cholesterol, mmol/l, median (IQR) 1.1 (0.9–1.3) 1.1 (0.9–1.3) 1.2 (1–1.6) 0.001
HDL cholesterol ≤1 mmol/l in men and ≤1.2 mmol/l in women, % 43.9 41.2 51.7 0.047
Triglycerides, mmol/l, median (IQR) 1.3 (1–1.8) 1.3 (1–1.9) 1.3 (1–1.7) 0.73
Triglycerides >1.7 mmol/l, % 30.2 31.2 27.5 0.45
Systolic blood pressure, mm Hg, median (IQR) 135 (120–147) 134 (120–146.3) 137.5 (120–148.3) 0.61
Systolic blood pressure ≥140 mm Hg, % 40 37.6 46.7 0.08
Diastolic blood pressure, mm Hg, median (IQR) 75 (69–84) 77 (70–84) 72 (64.8–80) 0.005
Diastolic blood pressure ≥90 mm Hg, % 11.7 12.4 10 0.48
a Body mass index >25 kg/m2
b Waist circumference >95 cm in men and >81 cm in women
Abbreviations: HbA1c, glycated hemoglobin; HDL, high‑density lipoprotein; LDL, low ‑density lipoprotein; others, see TAblE 1
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Pharmacotherapy Aldosterone antagonists 
were used by 19% of patients (19.7% of men and 
16.7% of women; P = 0.47), β ­blockers by 89.8% 
(89.4% of men and 90.8% of women; P = 0.66), cal­
cium channel blockers by 32% (28.9% of men and 
39.2% of women; P = 0.04), angiotensin convert­
ing enzyme inhibitors by 68.7% (72.6% of men 
and 57.5% of women; P = 0.002), and angioten­
sin II receptor blockers by 13% (11.8% of men and 
16.7% of women; P = 0.17). Diuretics were used 
by 48.9% (47.1% of men and 54.2% of women; 
P = 0.18) and statins by 93.5% of patients (95% 
of men and 89.2% of women; P = 0.03). Acetylsal­
icylic acid was taken by 89.6% of patients (90% of 
men and 88.3% of women, P = 0.6), while 50.2% 
of the group (54.4% of men and 38.3% of wom­
en, P = 0.003) were on dual antiplatelet thera­
py (33.5% on clopidogrel and 18.5% on ticagre­
lor). A total of 10.4% of patients did not use any 
antiplatelet medications (10% of men and 11.7% 
of women; P = 0.6) and 6.7% of individuals were 
on anticoagulant therapy due to atrial fibrilla­
tion (6.8% of men and 6.7% of women; P = 0.97).
A combination of β blocker or calcium channel 
blocker, angiotensin converting enzyme inhibi­
tor or angiotensin II receptor blocker, antiplate­
let or antithrombotic medications in case of atri­
al fibrillation, and a statin was used in 72.2% of 
patients (75.3% of men and 63.3% of women; P 
= 0.01). Three medications from these groups were 
taken in 22.4% (20.3% of men and 28.3% of wom­
en; P = 0.07), 2 in 3.7% (2.9% of men and 5.8% of 
women; P = 0.15), and 1 in 1.3% of cases (0.9% of 
men and 2.5% of women; P = 0.19). In 0.4% of pa­
tients (only men), no pharmacotherapy was used.
of coronary artery disease. Interestingly, 3.9% 
of patients did not care about the diet (4.7% 
of men and 1.7% of women). There was no dif­
ference between the sexes with respect to di­
etary changes (P = 0.28). Additionally, 78.5% 
of patients (77.4% of men and 81.7% of women; 
P = 0.29) declared that they avoided the con­
sumption of saturated fatty acids. A total of 
60.9% of patients (58.5% of men and 67.5% 
of women; P = 0.08) reduced the consumption 
of salt. Moreover, 33.5% of patients (32.6% of 
men and 35.8% of women; P = 0.52) declared 
an increase in fiber consumption. Only 34.6% 
of patients (34.4% of men and 35% of women; 
P = 0.92) consumed over 200 g of fruit per day 
and 35.4% consumed over 200 g of vegetables 
per day (30.6% of men and 49.2% of women, 
P <0.001). Fish consumption was low among 
the study population: only 21.1% of participants 
consumed fish at least 2 times per week (20% of 
men and 24.2% of women; P = 0.33) and 18.7% 
of patients (17.9% of men and 20.8% of wom­
en, P = 0.57) did not eat fish at all. More than 
a half of the patients (61.1%; 51.2% of men and 
89.2% of women; P <0.001) declared that they 
did not drink alcohol (FIgURE 1).
Although 14.6% of patients (15.3% of men and 
12.5% of women; P = 0.46) admitted that they 
were current smokers, 41% of all studied indi­
viduals used to be tobacco users, with a histo­
ry of median (IQR) 29 (15–40) pack ­years. For­
tunately, 63.2% of former smokers decided to 
give up smoking after developing symptoms of 












































































































































































































































Figure 1 Results of the questionnaire regarding dietary habits
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considerable positive changes in eating habits 
and tobacco use could be observed; 76.5% of pa­
tients declared that they had changed their diet 
after the diagnosis of coronary artery disease 
and as much as 63.2% of former smokers decid­
ed to give up smoking after developing symp­
toms of cardiovascular disease.
Much evidence has shown that a large propor­
tion of cardiovascular disease burden could be ex­
plained by behavioral factors, meanwhile our re­
sults and other large studies showed that a large 
majority of coronary disease patients had un­
healthy lifestyles.7,19 Promoting a healthy lifestyle 
(eg, physical activity, healthy diet, avoiding alcohol 
and tobacco use) has been crucial for the primary 
and secondary prevention of coronary artery dis­
ease. A dose ­response relationship between phys­
ical activity and cardiovascular disease morbidi­
ty and mortality has been described.20 However, 
there has not been a consensus on an appropri­
ate method of defining the level of physical ac­
tivity during medical control. Nevertheless, pa­
tients should be encouraged to be as physically ac­
tive as possible. Although a majority of patients 
declared a change in their diet since hospitaliza­
tion, more specific questions showed poor adher­
ence to the recommended healthy diet charac­
teristics. This highlighted the need to introduce 
targeted dietary advice promoting heart ­healthy 
eating habits that should be obligatory for all pa­
tients. One of the significant lifestyle factors was 
the consumption of tobacco. It was comforting 
that only 14.6% of patients from our cohort were 
active smokers; on the other hand, 41% of indi­
viduals smoked before the occurrence of cardio­
vascular events. Quitting smoking was associat­
ed with a substantial reduction in the risk of all­
­cause mortality among patients with diagnosed 
coronary heart disease and could be achieved 
relatively easy.21 A recent study by Siudak et al22 
showed that constant education of patients af­
ter myocardial infarction was an effective meth­
od of smoking cessation in over 50% of smokers 
6 months after myocardial infarction.
Hypertension has been one of the most sig­
nificant risk factors for the development of cor­
onary artery disease. A proper management of 
hypertension might significantly reduce the risk 
for secondary events. The SPRINT study (Systolic 
Blood Pressure Intervention Trial) revealed that 
in nondiabetic patients at a high risk of cardio­
vascular events, a target systolic blood pressure 
of less than 120 mm Hg, as compared with less 
than 140 mm Hg, resulted in 25% reduction of 
major cardiovascular events and 27% reduction 
of death from any cause. No significant decrease 
in stroke or myocardial infarction rate was de­
tected.23 Unattended automated office blood pres­
sure measurement was used in this study, which 
gives lower values than traditional methods of 
measurement. Thus, this value might correspond 
to conventional office systolic blood pressure in 
Implementation level of guidelines The analy­
sis comprised 5 secondary prevention goals which 
could be evaluated in the most objective way, that 
is: (1) normal weight (BMI 18.5–24.9 kg/m2); (2) 
no smoking status; (3) LDL cholesterol level be­
low 1.4 mmol/l; (4) normal levels of fasting glu­
cose for patients without diabetes mellitus (3.9–
5.5 mmol/l) and HbA1c for diabetic patients not 
exceeding 7%; and (5) systolic blood pressure be­
low 140 mm Hg and diastolic blood pressure be­
low 90 mm Hg. No patient fulfilled all the preven­
tion goals. Overall, 4 of these goals were fulfilled 
by 3.3%, 3 by 19.3%, 2 by 35.7%, and a single goal 
by 31.5% of patients. In 10.2% of cases none of the 
above ­mentioned criteria were achieved. A differ­
ence in the implementation level of guidelines was 
found between the sexes, with men being worse 
responders than women (P <0.001) (FIgURE 2).
dIscussIon Our study clearly showed that 
the level of adherence to the guidelines for sec­
ondary prevention of coronary artery disease 
was extremely low. Most of the patients (80.7%) 
did not comply with the body weight recommen­
dations, being either overweight or obese, which, 
in combination with a low level of physical ac­
tivity (declared by 56.7% of the studied patients) 
and bad dietary habits (low consumption of fi­
ber, fish, fruit, and vegetables), significantly in­
creased cardiovascular risk. Moreover, almost 
half of nondiabetic patients (43.5%) had fast­
ing blood glucose level exceeding 5.5 mmol/l and 
more than a half of diabetic patients (55.5%) had 
the HbA1c level higher than 7%. Also, hyperlip­
idemia was a considerable problem in the stud­
ied cohort, especially the level of LDL cholester­
ol, which was exceeded in over three ­fourths of 
patients (78.7% of cases). Insufficient manage­
ment of arterial blood pressure was also detect­
ed in almost half of patients (41.3%). Fortunately, 
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to the guidelines for secondary prevention of cor­
onary artery disease might be different in other 
centers. Second, not all but only the main, arbi­
trarily chosen factors that had an influence on 
the development of cardiovascular disease, were 
analyzed. Nevertheless, we believe that these lim­
itations did not significantly impede our analy­
ses and that the derived conclusions may be ex­
trapolated to the general population.
conclusions The  level of adherence to 
the guidelines for secondary prevention of cor­
onary artery disease was extremely low. No pa­
tient fulfilled all the prevention goals and in 
10.2% of cases none of the analyzed recommen­
dations were achieved. Significant difference in 
the implementation level of the guidelines was 
found between the sexes, with men being worse 
responders than women. More attention should 
be paid to proper implementation of the guide­
lines and patients’ education to prevent further 
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the range of 130 to 140 versus 140 to 150 mm Hg.16 
Moreover, a large meta ­analysis of 147 randomized 
trials showed that a reduction of systolic blood 
pressure by 10 mm Hg, or diastolic by 5 mm Hg, 
reduced coronary heart disease events by about 
one ­quarter and stroke by about one­third.24 Un­
fortunately, the recommended value of blood pres­
sure was not achieved by 41.3% of our patients. 
Moreover, if we had taken a more restricted tar­
get for patients with diabetes (<130/80 mm Hg), 
as much as 69.8% of individuals from our studied 
cohort would not have reached the recommended 
levels. That indicated that more actions should be 
taken by both patients and clinicians to manage 
this important risk factor.
The  current study found significant sex­
­related differences in the implementation of 
the guidelines. Generally, men were worse re­
sponders than women. Nevertheless, among all 
studied factors, diabetic women achieved worse 
glycemic control than men and they had worse 
control of total cholesterol and HDL fraction 
cholesterol levels.
Strenuous efforts should be made to improve 
the adherence to secondary prevention guidelines, 
which would result in slowing the progression of 
the disease, reducing secondary events and mor­
tality, improving the quality of life, and reduc­
ing the number of hospitalizations.7,19 Moreover, 
optimized and streamlined patient care may re­
duce the use of personnel and financial resourc­
es.25 Most cardiovascular risk factors could be 
modified and controlled. In our opinion, frequent 
control visits to a specialist or general practitio­
ner would enable to improve the obtained re­
sults. Currently, this measure is already imple­
mented in Poland for patients after a myocardi­
al infarction. Continued follow ­up visits and re­
peated blood tests will allow to reduce the risk of 
the recurrence of cardiovascular events. A com­
bination of patients’ education and professional 
and practical advice on the possibilities of life­
style change and regular medical control should 
be implemented during any contact with medi­
cal staff. Moreover, nationwide secondary pre­
vention programs and advertising campaigns 
directed to patients should be intensified to im­
prove the processes of care. To increase the level 
of implementation, the process should be moni­
tored by audits, surveys, or by assessing outcome 
data.25 On the other hand, physicians must be 
regularly trained and educated on how to prop­
erly implement the guidelines into their clinical 
practice.26 Finally, social media and mobile med­
ical software applications may be used as power­
ful and widely available tools to help implement 
the clinical guidelines.27
limitations There are 2 main limitations of 
the study that should be considered. First, this 
was a single ­center study focused on a local popu­
lation of patients, therefore the level of adherence 
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